Related Experiment Videos
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells
1Dipartimento di Istologia ed Embriologia Medica, Università "La Sapienza," 00161 Rome, Italy.
Abstract:
Myogenic cell differentiation is induced by Arg(8)-vasopressin, whereas high cAMP levels and protein kinase A (PKA) activity inhibit myogenesis. We investigated the role of type 4 phosphodiesterase (PDE4) during L6-C5 myoblast differentiation. Selective PDE4 inhibition resulted in suppression of differentiation induced by vasopressin. PDE4 inhibition prevented vasopressin-induced nuclear translocation of the muscle-specific transcription factor myogenin without affecting its overall expression level. The effects of PDE4 inhibition could be attributed to an increase of cAMP levels and PKA activity. RNase protection, reverse transcriptase PCR, immunoprecipitation, Western blot, and enzyme activity assays demonstrated that the PDE4D3 isoform is the major PDE4 expressed in L6-C5 myoblasts and myotubes, accounting for 75% of total cAMP-hydrolyzing activity. Vasopressin cell stimulation caused a biphasic increase of PDE4 activity, which peaked at 2 and 15 min and remained elevated for 48 h. In the continuous presence of vasopressin, cAMP levels and PKA activity were lowered. PDE4D3 overexpression increased spontaneous and vasopressin-dependent differentiation of L6-C5 cells. These results show that PDE4D3 plays a key role in the control of cAMP levels and differentiation of L6-C5 cells. Through the modulation of PDE4 activity, vasopressin inhibits the cAMP signal transduction pathway, which regulates myogenesis possibly by controlling the subcellular localization of myogenin.
Insights
Type 4 phosphodiesterase (PDE4) regulates muscle cell differentiation. PDE4D3 isoform controls cyclic AMP (cAMP) levels, influencing myogenesis by affecting myogenin nuclear translocation.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Myogenic cell differentiation is a complex process regulated by signaling pathways.
- Arginine(8)-vasopressin (AVP) induces myogenesis, while elevated cyclic AMP (cAMP) and protein kinase A (PKA) inhibit it.
Purpose of the Study:
- To investigate the role of type 4 phosphodiesterase (PDE4) in L6-C5 myoblast differentiation.
- To elucidate the specific PDE4 isoform involved and its mechanism of action.
Main Methods:
- Selective PDE4 inhibition
- RNase protection assays
- Reverse transcriptase PCR
- Immunoprecipitation
- Western blotting
- Enzyme activity assays
- Overexpression studies
Main Results:
- Selective PDE4 inhibition suppressed AVP-induced differentiation and prevented myogenin nuclear translocation.
- The PDE4D3 isoform was identified as the major cAMP-hydrolyzing enzyme in L6-C5 cells.
- AVP stimulation transiently increased PDE4 activity, leading to decreased cAMP and PKA activity.
- PDE4D3 overexpression enhanced both spontaneous and AVP-dependent differentiation.
Conclusions:
- PDE4D3 plays a critical role in regulating cAMP levels and L6-C5 cell differentiation.
- AVP modulates myogenesis by inhibiting the cAMP signaling pathway, potentially via control of myogenin subcellular localization through PDE4 activity.